Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 90

Results For "study"

1396 News Found

Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
Drug Approval | May 08, 2023

Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007

APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery


PredOmix launches campaign for free cancer screening
Healthcare | May 05, 2023

PredOmix launches campaign for free cancer screening

PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy


Yuyu Pharma unveils the results of its studies for its dry eye treatment peptide
News | April 28, 2023

Yuyu Pharma unveils the results of its studies for its dry eye treatment peptide

The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science


Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India
News | April 25, 2023

Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India

CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology


Indica Labs and Lunit enters into alliance for digital pathology AI workflows
Digitisation | April 25, 2023

Indica Labs and Lunit enters into alliance for digital pathology AI workflows

Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


Moderna and Merck announce an investigational individualized neoantigen therapy
Clinical Trials | April 17, 2023

Moderna and Merck announce an investigational individualized neoantigen therapy

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients


Digital Health: An opportunity to increase health equity
Digitisation | April 14, 2023

Digital Health: An opportunity to increase health equity

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%


Advanced library amplification mix delivers superior NGS data quality
Digitisation | April 14, 2023

Advanced library amplification mix delivers superior NGS data quality

NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.


Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh
News | April 10, 2023

Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh

He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir